Gi Hong Choi
연세대학교 의공학부 · 의학
Gi Hong Choi 교수의 연구실은 간암 및 간질환 치료 분야에서 최신 로봇 수술 기법과 병용된 간암 절제술의 임상적 성과를 중심으로 연구를 진행하고 있습니다. 특히 로봇 수술을 활용한 간세포암종 절제술의 표준화된 절차 개발과, 병변의 특성 및 간기능 상태에 따른 수술 적응증 평가에 중점을 두고 있습니다. 또한, 수술 전 동통치료(TACE)의 효과에 대한 임상적 의의를 분석하여, 치료 전략 수립에 기여하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
Since the robotic surgical system was first introduced in 2005, the number of robotic surgery has been gradually increasing in Korea. The proportion of general robotic surgery is relatively higher compared to the western countries, but robotic liver resection is one of the most complex procedures among robotic general surgery. In this article, we introduce the development of robotic liver resection in Korea and describe our standardized techniques. The current data on robotic liver resection in
In Child-Pugh A cirrhotic patients, the presence of clinically significant PHT was significantly associated with post-operative hepatic decompensation and poor prognosis after resection of HCC. However, in patients with clinically significant PHT, those with single nodular tumours lacking gross vascular invasion may be good surgical candidates.
Preoperative TACE did not significantly improve the disease-free survival or the pattern of recurrence after curative resection of HCC. Even though this study is a retrospective analysis, preoperative TACE cannot be recommended as a routine procedure before hepatectomy for a resectable HCC.
